Microbial Contamination of Hematopoietic Stem Cell Products: Incidence and Clinical Sequelae

Biology of Blood and Marrow Transplantation

Volumn 12, Issue 11, 2006, Pages 1142-1149

  Klein, Mark A ^a   Kadidlo, Diane ^b   McCullough, Jeffrey ^a   McKenna, David H ^a   Burns, Linda J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Hematopoietic stem cell transplantation; Microbial contamination; Stem cell products

Indexed keywords

AMIKACIN; CEFAZOLIN; CEFOPERAZONE; CEFOTAXIME; CEFTAZIDIME; CHLORAMPHENICOL; COTRIMOXAZOLE; DIPHENHYDRAMINE; GAMMA INTERFERON; GENTAMICIN; HYDROCORTISONE; HYPERTENSIVE FACTOR; LORAZEPAM; MEZLOCILLIN; PARACETAMOL; PIPERACILLIN; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN; VANCOMYCIN;

ADULT; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BLOOD CULTURE; BURKHOLDERIA CEPACIA; CELL CULTURE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INFECTION RISK; MALE; MICROBIAL CONTAMINATION; TREATMENT OUTCOME;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; ANTIBIOTIC PROPHYLAXIS; BACTEREMIA; BURKHOLDERIA CEPACIA; CHILD; CHILD, PRESCHOOL; CROSS INFECTION; CRYOPRESERVATION; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; HUMANS; INCIDENCE; INFANT; INFECTION CONTROL; MALE; MIDDLE AGED; MINNESOTA; RETROSPECTIVE STUDIES; STAPHYLOCOCCUS;

EID: 33750521005     PISSN: 10838791     EISSN: 15236536     Source Type: Journal    
DOI: 10.1016/j.bbmt.2006.06.011     Document Type: Article

References (23)

1. Schepers H.G., Davis J.M., and Rowley S.D. Incidence of bacterial contamination of bone marrow grafts. Prog Clin Biol Res 377 (1992) 379-384
2. D'Antonio D., Iacone A., Fioritoni G., et al. Detection of bacterial contamination in bone marrow graft. Haemotolgica 76 suppl 1 (1991) 44-45
3. Rowley S.D., Davis J., Dick J., et al. Bacterial contamination of bone marrow grafts intended for autologous and allogeneic bone marrow transplantation: incidence and clinical significance. Transfusion 28 (1988) 109-112
4. Farrinton M., Matthews I., Marcus R., Scott M.A., Caffrey E., and Hunt C.J. Contamination of bone marrow transplants from peripheral blood. BMJ 309 (1994) 958
5. Schwella N., Zimmermann R., Heuft H.G., et al. Microbiologic contamination of peripheral blood stem cell autografts. Vox Sang 67 (1994) 32-35
6. Prince H.M., Page S.R., Keating A., et al. Microbial contamination of harvested bone marrow and peripheral blood. Bone Marrow Transplant 15 (1995) 87-91
7. Padley D., Koontz F., Trigg M.E., Gingrich R., and Strauss R.G. Bacterial contamination rates following processing of bone marrow and peripheral blood progenitor cell preparations. Transfusion 36 (1996) 53-56
8. Espinosa M.T.F., Fox R., Creger R.J., and Lazarus H.M. Microbiologic contamination of peripheral blood progenitor cells collected for hematopoietic cell transplantation. Transfusion 36 (1996) 789-793
9. Attarian H., Bensinger W.I., Buckner C.D., McDonald D.L., and Rowley S.D. Microbial contamination of peripheral blood stem cell collections. Bone Marrow Transplant 17 (1996) 699-702
10. Smith D., Bradley S.J., and Scott G.M. Bacterial contamination of autologous bone marrow during processing. J Hosp Infect 33 (1996) 71-76
11. Jestice H.K., Farrington M., Hunt C., et al. Bacterial contamination of peripheral blood progenitor cells for transplantation. Transfus Med 6 (1996) 103-110
12. Webb I.J., Coral F.S., Andersen J.W., et al. Sources and sequelae of bacterial contamination of hematopoietic stem cell components: implications for the safety of hematotherapy and graft engineering. Transfusion 36 (1996) 782-788
13. Farrington M., Matthews I., Jestice H.K., et al. Bacterial contamination of autologous bone marrow during processing. J Hosp Infect 34 (1996) 230-233
14. Fountain D., Ralston M., Higgins N., et al. Liquid nitrogen freezers: a potential source of microbial contamination of hematopoietic stem cell components. Transfusion 37 (1997) 585-591
15. Schwella N., Rick O., Heuft H.G., et al. Bacterial contamination of autologous bone marrow: reinfusion of culture-positive grafts does not result in clinical sequelae during the posttransplantation course. Vox Sang 74 (1998) 88-94
16. Lowder J.N., and Whelton P. Microbial contamination of cellular products for hematolymphoid transplantation therapy: assessment of the problem and strategies to minimize the clinical impact. Cytotherapy 5 (2003) 377-390
17. Hirji Z., Saragosa R., Dedier H., et al. Contamination of bone marrow products with an actinomycete resembling microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients. Clin Infect Dis 36 (2003) e115-e121
18. Kamble R., Pant S., Selby G.B., et al. Microbial contamination of hematopoietic progenitor cell grafts-incidence, clinical outcome, and cost-effectiveness: an analysis of 735 grafts. Transfusion 45 (2005) 874-878
19. Larrea L., de La Rubia J., Soler M.A., et al. Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation. Haematologica 89 (2004) 1232-1237
20. Nifong T.P., Ehmann W.C., Mierski J.A., Domen R.E., and Rybka W.B. Favorable outcome after infusion of coagulase-negative staphylococci-contaminated peripheral blood hematopoietic cells for autologous transplantation. Arch Pathol Lab Med 127 (2003) e19-e21
21. In: Brecher M.E. (Ed). American Association of Blood Banks Technical Manual. 13th ed (2005), American Association of Blood Banks, Bethesda, MD
22. Current good tissue practice for human cell, tissue and cellular and tissue-based products establishments; inspection and enforcement; final rule. FDA 21 CFR parts 16, 1270 and 1271, docket no. 1997N-484P. Fed Reg 69 226 (2004)
23. Wagner S.J., Robinette D., Friedman L.I., and Miripol J. Diversion of initial blood flow to prevent whole-blood contamination by skin surface bacteria: an in vitro model. Transfusion 40 (2000) 335-338